Engineers Gate Manager’s Dr. Reddy's Laboratories RDY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
– Sell
-23,375
Closed -$371K – 2517
2024
Q3
$371K Buy
23,375
+3,500
+18% +$56.3K 0.01% 1528
2024
Q2
$303K Buy
19,875
+3,490
+21% +$50K 0.01% 1461
2024
Q1
$240K Buy
+16,385
New +$239K 0.01% 1576
2023
Q4
– Sell
-57,225
Closed -$765K – 2194
2023
Q3
$765K Buy
+57,225
New +$774K 0.03% 855
2023
Q2
– Sell
-37,230
Closed -$424K – 1973
2023
Q1
$424K Buy
37,230
+14,755
+66% +$159K 0.02% 1062
2022
Q4
$233K Buy
+22,475
New +$242K 0.01% 1311

Other funds holding RDY

Engineers Gate Manager's RDY Position: Q4 2024 in Review

Engineers Gate Manager sold out of Dr. Reddy's Laboratories (RDY) in Q4 2024, closing a stake of 23,375 shares — an estimated $371K sold.

Engineers Gate Manager first reported a position in RDY in Q4 2022 and held it in 6 quarters. The position peaked at $765K in Q3 2023. 248 funds tracked by Wall St. Rank hold RDY as of Q4 2024.

  • Engineers Gate Manager reported no remaining Dr. Reddy's Laboratories position as of Q4 2024 after selling out during the quarter.
  • Engineers Gate Manager sold 23,375 Dr. Reddy's Laboratories shares in Q4 2024, an estimated $371K.
  • Engineers Gate Manager first reported a position in Dr. Reddy's Laboratories in Q4 2022 and held it in 6 quarters.
  • Engineers Gate Manager's Dr. Reddy's Laboratories position peaked at $765K in Q3 2023.
  • 248 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q4 2024.

Based on Engineers Gate Manager's 13F filing for Q4 2024, filed 14 Feb 2025.